Frank Madeo
Papers
1
Total Citations
77
H-Index
1
About
Frank Madeo is a pioneering figure in autophagy research and the biology of aging, whose work has fundamentally reshaped our understanding of how cellular recycling mechanisms can combat age-related diseases. His key research areas span autophagy modulation, caloric restriction mimetics, and the molecular pathways linking metabolism to longevity. Madeo is best known for identifying spermidine as a potent, natural autophagy inducer and for demonstrating its life-extending effects across multiple species—a discovery with profound translational implications. His highly cited 2021 study on IGF1 receptor inhibition revealed that blocking this pathway amplifies the efficacy of cancer drugs through both autophagy-dependent and immune-mediated mechanisms, opening new avenues for combination cancer therapies. With thousands of citations across his body of work, Madeo’s contributions have established autophagy enhancement as a viable therapeutic strategy for neurodegeneration, cancer, and aging. He has received numerous accolades, including the prestigious Wittgenstein Award, and his research continues to bridge fundamental cell biology with clinical applications, making him a leading voice in the quest to extend healthspan.
Research Focus
Key Achievements
Top Papers
- 1